HCRT and COVID-19: There were no significant differences in orexin A plasma concentrations in COVID-19 patients depending on their requirement for oxygen supplementation (ROS; n=26), need for noninvasive ventilation (NIV; n=5), mechanical ventilation (MV; n=25), and the implementation of ECMO (n=20; Fig. 3c).